CCMD
ELV icon

Cypress Capital Management (Delaware)’s Elevance Health ELV Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,529
Closed -$1.15M – 53
2022
Q3 		$1.15M Sell
2,529
-85
-3% -$40.7K 0.21% 81
2022
Q2 		$1.26M Sell
2,614
-25
-0.9% -$12.4K 0.19% 87
2022
Q1 		$1.3M Sell
2,639
-185
-7% -$84.6K 0.16% 96
2021
Q4 		$1.31M Sell
2,824
-80
-3% -$33.7K 0.15% 103
2021
Q3 		$1.11M Hold
2,904
– – 0.15% 101
2021
Q2 		$1.11M Sell
2,904
-385
-12% -$147K 0.15% 102
2021
Q1 		$1.18M Sell
3,289
-110
-3% -$35.4K 0.16% 92
2020
Q4 		$1.09M Hold
3,399
– – 0.15% 95
2020
Q3 		$913K Sell
3,399
-500
-13% -$135K 0.14% 98
2020
Q2 		$1.02M Hold
3,899
– – 0.17% 87
2020
Q1 		$885K Sell
3,899
-50
-1% -$13.6K 0.17% 82
2019
Q4 		$1.19M Hold
3,949
– – 0.18% 84
2019
Q3 		$948K Sell
3,949
-80
-2% -$21.9K 0.16% 87
2019
Q2 		$1.14M Sell
4,029
-285
-7% -$77.9K 0.2% 78
2019
Q1 		$1.24M Sell
4,314
-850
-16% -$246K 0.23% 66
2018
Q4 		$1.36M Sell
5,164
-25
-0.5% -$6.87K 0.28% 54
2018
Q3 		$1.42M Sell
5,189
-60
-1% -$15.6K 0.25% 56
2018
Q2 		$1.25M Buy
5,249
+190
+4% +$44K 0.24% 61
2018
Q1 		$1.11M Sell
5,059
-724
-13% -$170K 0.21% 65
2017
Q4 		$1.3M Buy
5,783
+99
+2% +$21.1K 0.25% 59
2017
Q3 		$1.08M Buy
5,684
+195
+4% +$37.1K 0.23% 61
2017
Q2 		$1.03M Buy
5,489
+1,885
+52% +$339K 0.25% 58
2017
Q1 		$596K Buy
3,604
+1,394
+63% +$222K 0.15% 64
2016
Q4 		$318K Buy
+2,210
New +$296K 0.08% 86

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cypress Capital Management (Delaware)'s ELV Position: Q4 2022 in Review

Cypress Capital Management (Delaware) sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 2,529 shares — an estimated $1.15M sold.

Cypress Capital Management (Delaware) first reported a position in ELV in Q4 2016 and held it in 24 quarters. The position peaked at $1.42M in Q3 2018. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Cypress Capital Management (Delaware) reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 2,529 Elevance Health shares in Q4 2022, an estimated $1.15M.
  • Cypress Capital Management (Delaware) first reported a position in Elevance Health in Q4 2016 and held it in 24 quarters.
  • Cypress Capital Management (Delaware)'s Elevance Health position peaked at $1.42M in Q3 2018.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2022.